Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Oxidative Stress and Emergence of Psychosis
Victoria Rambaud, Aude Marzo, Boris Chaumette
Antioxidants (2022) Vol. 11, Iss. 10, pp. 1870-1870
Open Access | Times Cited: 19
Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis
Yang Mi, Chunzhi Wang, Guocheng Zhao, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 2, pp. 340-352
Open Access | Times Cited: 16
Positive Effects of Uric Acid on White Matter Microstructures and Treatment Response in Patients With Schizophrenia
Minji Bang, Yul Heo, Tai Kiu Choi, et al.
Schizophrenia Bulletin (2024) Vol. 50, Iss. 4, pp. 815-826
Closed Access | Times Cited: 3
Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia
V. Djordjevic, Jelena Kostić, Žilijeta Krivokapić, et al.
Medicina (2022) Vol. 58, Iss. 10, pp. 1491-1491
Open Access | Times Cited: 13
Pro/Antioxidant State as a Potential Biomarker of Schizophrenia
Dariusz Juchnowicz, Michał Dzikowski, Joanna Róg, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4156-4156
Open Access | Times Cited: 14
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study
Haixia Liu, Hua Liu, Shuling Jiang, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1793-1803
Open Access | Times Cited: 13
Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study
Zhiwei Wu, Qinqin Liu, Yinghua Zhang, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 2, pp. 128-135
Open Access | Times Cited: 11
Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
Zhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Inhibition of reactive oxygen species production accompanying alternatively activated microglia by risperidone in a mouse ketamine model of schizophrenia
Risako Fujikawa, Jun Yamada, Shoichiro Maeda, et al.
Journal of Neurochemistry (2024)
Closed Access | Times Cited: 1
Relevance of diet in schizophrenia: a review focusing on prenatal nutritional deficiency, obesity, oxidative stress and inflammation
Viorica Rarinca, Amalia Vasile, Mălina Visternicu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Assessment of nanoliposomes loaded with daidzein for ameliorating diabetes in alloxan-induced mice: A promising nutraceutical approach
N Rad, Ehsan Karimi, Homa Mahmoodzadeh Akherat, et al.
Journal of Functional Foods (2023) Vol. 110, pp. 105848-105848
Open Access | Times Cited: 3
Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
Keqiang Wang, Meihong Xiu, Xiuru Su, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 646-646
Open Access | Times Cited: 4
Factor analysis of the relationship between PANSS score and family burden of patients with schizophrenia
Jiang Huang, Wei‐Xiang Wei, Panpan Zheng, et al.
Brain and Behavior (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 5
Therapeutic action of ashwagandha extract on apoptosis and cell proliferation in the heart of rat fetuses prenatally treated with clozapine
Hend T. El‐Borm, Gamal M. Badawy, Fatma A. Sherifa, et al.
Egyptian Journal of Basic and Applied Sciences (2024) Vol. 11, Iss. 1, pp. 253-268
Open Access
Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort Study
Meihong Xiu, Xiuli Song, Hanlun Yang, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 10, pp. 2151-2158
Open Access | Times Cited: 1
Smoke, GPx activity and symptoms improvement in patients with drug-naive first-episode schizophrenia: A large-scale 12-week follow-up study
Nan Chen, Haixia Liu, Jing Yao, et al.
Asian Journal of Psychiatry (2022) Vol. 77, pp. 103267-103267
Closed Access | Times Cited: 2
Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia
Xuan Wang, Meihong Xiu, Keqiang Wang, et al.
Metabolomics (2022) Vol. 18, Iss. 7
Closed Access | Times Cited: 1
Influence of glutathione-related genetic variants on the oxidative stress profile of Mexican patients with psychotic disorders
Yerye Gibrán Mayén-Lobo, Mireya Alcaraz-Zubeldia, David José Dávila‐Ortiz de Montellano, et al.
Brazilian Journal of Psychiatry (2022)
Open Access | Times Cited: 1
Role of Antioxidants, and Lifestyle in Managing Brain Disorders Oxidative Stress Biomarkers and Antioxidant Treatments in Brain Diseases
Öznur Özge Özcan, Mesut Karahan, Muhsin Konuk
Food bioactive ingredients (2023), pp. 249-267
Closed Access
Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study
Zhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1733-1741
Open Access
Page 1

Scroll to top